Related Experiment Video
Updated: Mar 14, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Mesenchymal stem cell: a new horizon in cancer gene therapy
M Mohammadi1, M R Jaafari2, H R Mirzaei3
1Hepatitis Research Center and Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran.
Abstract:
Cancer is one of the main problems in public health worldwide. Despite rapid advances in the diagnosis and treatment of cancer, the efficacy of current treatment strategies is still limited. There are promising new results in animal models whereby mesenchymal stem cells (MSCs) can be used as vehicles for targeted therapies. The use of MSCs as therapeutic biological vehicles in cell therapy has several advantages, including immune-silence, tumor tropism, easy and rapid isolation, ex vivo expansion, multilineage differentiation and the capacity to deliver a number of therapeutic agents. Some studies have shown that the microenvironment of the tumor provides a preferential niche for homing and survival of MSCs. Here, we have highlighted various applications of MSCs in cancer gene therapy.
Insights
Mesenchymal stem cells (MSCs) show promise as targeted therapy vehicles for cancer treatment. Their unique properties, like tumor tropism and immune-silence, make them ideal for delivering therapeutic agents in gene therapy applications.
Area of Science:
- Oncology
- Stem Cell Biology
- Gene Therapy
Background:
- Cancer remains a significant global public health challenge with limited treatment efficacy.
- Mesenchymal stem cells (MSCs) are emerging as potential therapeutic agents in preclinical cancer models.
Purpose of the Study:
- To highlight the diverse applications of mesenchymal stem cells (MSCs) in advancing cancer gene therapy strategies.
Main Methods:
- Review of existing literature on MSCs in cancer research.
- Analysis of MSC properties relevant to targeted cancer therapy.
- Exploration of MSCs as delivery vehicles for therapeutic agents.
Main Results:
- MSCs possess advantageous characteristics for cancer therapy, including immune-silence and tumor tropism.
- The tumor microenvironment supports MSC homing and survival, enhancing their therapeutic potential.
- MSCs can be readily isolated, expanded ex vivo, and engineered to deliver therapeutic payloads.
Conclusions:
- Mesenchymal stem cells offer a promising platform for novel cancer gene therapy approaches.
- The inherent properties of MSCs facilitate targeted delivery and enhanced therapeutic outcomes in preclinical cancer models.
Related Concept Videos
Mesenchymal Stem Cells
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Induced Pluripotent Stem Cells
Somatic...
Targeted Cancer Therapies
There are several types of targeted therapies against...

